Rua Bioscience Limited (NZE:RUA)
New Zealand
· Delayed Price · Currency is NZD 0.0330
+0.0010 (3.13%)
At close: Mar 10, 2026
Rua Bioscience Revenue
Rua Bioscience had revenue of 1.46M NZD in the half year ending December 31, 2025, with 929.17% growth. This brings the company's revenue in the last twelve months to 2.39M, up 124.84% year-over-year. In the fiscal year ending June 30, 2025, Rua Bioscience had annual revenue of 1.83M with 477.39% growth.
Revenue (ttm)
2.39M
Revenue Growth
+124.84%
P/S Ratio
4.52
Revenue / Employee
n/a
Employees
n/a
Market Cap
10.82M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Fisher & Paykel Healthcare Corporation | 2.16B |
| EBOS Group | 15.12B |
| Summerset Group Holdings | 360.86M |
| Ryman Healthcare | 807.48M |
| Pacific Edge | 18.24M |
| Green Cross Health | 528.32M |
| Radius Residential Care | 192.26M |
| Third Age Health Services | 20.32M |